Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 50451-50500 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05129150
Cognitive Disorders and Brain Pulse
N/ARecruiting
300 participants
Started: Mar 31, 2022 · Completed: Mar 31, 2031
1 condition1 sponsor1 location
NCT05142605
Evaluation of Grief Therapy Approaches for Bereaved Parents
NARecruiting
415 participants
Started: Mar 31, 2022 · Completed: May 31, 2026
3 conditions2 sponsors4 locations
NCT05243693
Brentuximab Vedotin Plus DHAP in Relapsed or Refractory Hodgkin's Lymphoma
PHASE2Recruiting
30 participants
Started: Mar 31, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT06239415
PAtients With Symptomatic Peripheral Artery Disease on Rivaroxaban-acetylsalicylic Acid Combination Therapy (PRO-PAS)
N/ARecruiting
250 participants
Started: Mar 31, 2022 · Completed: Mar 31, 2024
1 condition2 sponsors1 location
NCT05272969
Pompe & Pain - Study to Assess Nociceptive Pain in Adult Patients With Pompe Disease
N/ARecruiting
95 participants
Started: Mar 31, 2022 · Completed: Sep 3, 2024
4 conditions1 sponsor1 location
NCT05278975
Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma
PHASE1/PHASE2Recruiting
186 participants
Started: Mar 31, 2022 · Completed: Apr 1, 2025
6 conditions1 sponsor10 locations
NCT05101187
Olorofim Aspergillus Infection Study
PHASE3Recruiting
225 participants
Started: Mar 31, 2022 · Completed: Nov 1, 2026
1 condition3 sponsors140 locations
NCT05290857
Anticoagulation After GI Bleeding Pilot Study and Registry
NARecruiting
100 participants
Started: Mar 31, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor2 locations
NCT05323357
Bern Human Organoid-Study to Study Host-microbe Interaction
N/ARecruiting
100 participants
Started: Mar 31, 2022 · Completed: Mar 30, 2026
3 conditions2 sponsors1 location
NCT05349318
Hyperbaric Oxygen Therapy for Prodromal Alzheimer´s Disease With Cerebrovascular Disease
NARecruiting
100 participants
Started: Mar 31, 2022 · Completed: Mar 31, 2025
4 conditions1 sponsor1 location
NCT06428487
Neoadjuvant Prolgolimab Monotherapy in Locally Advanced MMR-deficient Colorectal Cancer
PHASE2Recruiting
30 participants
Started: Mar 31, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT04979052
Safety and Efficacy of Interferon-Gamma 1b in Patients With Candidemia
PHASE2Recruiting
200 participants
Started: Mar 31, 2022 · Completed: Jun 30, 2026
1 condition2 sponsors6 locations
NCT05237232
Modeling of Intracerebral Vascularization After Extracorporeal Membrane Oxygenation in Children
N/ARecruiting
30 participants
Started: Mar 31, 2022 · Completed: Aug 31, 2026
2 conditions2 sponsors1 location
NCT05269381
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
PHASE1/PHASE2Recruiting
36 participants
Started: Mar 31, 2022 · Completed: Feb 24, 2026
130 conditions1 sponsor1 location
NCT06141408
PrEP Intervention in Prince George's County, Maryland
NARecruiting
120 participants
Started: Mar 31, 2022 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT04791488
Impact of Hyperoxia and Involvement of the Immune System in Diving Accident
NARecruiting
265 participants
Started: Mar 30, 2022 · Completed: Mar 30, 2028
1 condition1 sponsor1 location
NCT05451628
Anatomy-Based Fitting in Unexperienced Cochlear Implant Users
NARecruiting
40 participants
Started: Mar 30, 2022 · Completed: Jan 31, 2025
2 conditions1 sponsor1 location
NCT05616507
Oligo-Fucoidan Decrease Lung Radiation Damage
NARecruiting
100 participants
Started: Mar 30, 2022 · Completed: Dec 30, 2025
1 condition2 sponsors1 location
NCT04698031
Efficacy of Clopidogrel on Incidence of Silent Brain Infarction
PHASE4Recruiting
125 participants
Started: Mar 30, 2022 · Completed: May 30, 2026
1 condition1 sponsor1 location
NCT05257993
Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic Cancer
PHASE1Recruiting
30 participants
Started: Mar 30, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor4 locations
NCT05118854
A Phase II Study of Neoadjuvant Sotorasib in Combination With Cisplatin or Carboplatin and Pemetrexed for Surgically Resectable Stage IIA-IIIB Non-Squamous Non-Small Cell Lung Cancer With a KRAS p.G12C Mutation
PHASE2Recruiting
27 participants
Started: Mar 30, 2022 · Completed: Oct 20, 2027
1 condition2 sponsors2 locations
NCT05145764
Suvorexant as an Adjunct to Buprenorphine in Persons Who Use Fentanyl
PHASE2Recruiting
120 participants
Started: Mar 30, 2022 · Completed: Aug 31, 2026
3 conditions2 sponsors1 location
NCT05312879
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1- Mediated Proteinuric Kidney Disease
PHASE2/PHASE3Recruiting
466 participants
Started: Mar 30, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor314 locations
NCT04372615
The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis
PHASE2Recruiting
116 participants
Started: Mar 30, 2022 · Completed: Sep 30, 2028
2 conditions1 sponsor39 locations
NCT05250037
The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)
N/ARecruiting
250 participants
Started: Mar 30, 2022 · Completed: Jun 30, 2028
2 conditions2 sponsors4 locations
NCT04985266
A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer
PHASE2Recruiting
1,100 participants
Started: Mar 30, 2022 · Completed: Sep 1, 2030
2 conditions7 sponsors49 locations
NCT05108259
To Compare the Pharmacokinetics and Safety of PBP1502 and Humira in Healthy Subjects
PHASE1Recruiting
324 participants
Started: Mar 30, 2022 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT04990895
A Research Study to Collect Patient Reported Outcomes Using Electronic Surveys
NARecruiting
128 participants
Started: Mar 30, 2022 · Completed: Oct 1, 2026
2 conditions2 sponsors1 location
NCT05009160
DreaMS - Validation Study 1
N/ARecruiting
300 participants
Started: Mar 30, 2022 · Completed: Mar 31, 2027
1 condition7 sponsors6 locations
NCT05116904
Smith Magenis Syndrome and Autism Spectrum Disorders
NARecruiting
40 participants
Started: Mar 30, 2022 · Completed: Apr 30, 2026
2 conditions1 sponsor2 locations
NCT05320627
Population Pharmacokinetics of Edoxaban in Chinese Patients With Non-Valvular Atrial Fibrillation
PHASE4Recruiting
120 participants
Started: Mar 30, 2022 · Completed: Dec 30, 2024
1 condition2 sponsors1 location
NCT05199857
WE BEAT - HEART Club Fontan Wellness Project: A Virtual Resilience Promotion and Frailty Prevention Program
NARecruiting
30 participants
Started: Mar 30, 2022 · Completed: Jul 31, 2026
3 conditions2 sponsors1 location
NCT05145647
To Observe the Benefit of Adding Brachytherapy After CCRT on Resectable Esophageal Cancer Patients Without Surgery
NARecruiting
18 participants
Started: Mar 30, 2022 · Completed: Jun 18, 2025
1 condition1 sponsor1 location
NCT05410977
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
N/ARecruiting
750 participants
Started: Mar 30, 2022 · Completed: Apr 1, 2027
2 conditions2 sponsors9 locations
NCT05224414
Interpretation Bias as a Mechanism of Treatment Response in OCD
NARecruiting
106 participants
Started: Mar 30, 2022 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT05186948
Development and Validation of a Novel Functional Eye-Tracking Software Application for Cancer-related Cognitive Impairment (CRCI)
N/ARecruiting
230 participants
Started: Mar 30, 2022 · Completed: Jan 20, 2025
1 condition1 sponsor1 location
NCT05248230
4D-710 in Adult Patients With Cystic Fibrosis
PHASE1/PHASE2Recruiting
40 participants
Started: Mar 29, 2022 · Completed: Jan 31, 2030
1 condition1 sponsor19 locations
NCT06654648
Combined Exercise and Nutrition Intervention for Sarcopenia
NARecruiting
118 participants
Started: Mar 29, 2022 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT05201859
Adjuvant Sintilimab Plus Capecitabine in Nasopharyngeal Carcinoma
PHASE2Recruiting
150 participants
Started: Mar 29, 2022 · Completed: Feb 15, 2026
1 condition1 sponsor1 location
NCT05336695
Assess Fibrin in Brains With AD/ADRD
PHASE1/PHASE2Recruiting
30 participants
Started: Mar 29, 2022 · Completed: Sep 28, 2026
2 conditions2 sponsors1 location
NCT04800393
The Impact of Inhalation vs Total Intravenous Anesthesia on the Immune Status and Mortality in Patients Undergoing Breast Cancer Surgery: a Prospective Double-Blind Randomized Clinical Trial.
NARecruiting
130 participants
Started: Mar 29, 2022 · Completed: Apr 1, 2028
2 conditions2 sponsors1 location
NCT05030038
Oral Aromatase Inhibitors Modify the Gut Microbiome
N/ARecruiting
25 participants
Started: Mar 29, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05387304
A Follow-up Study of Asymptomatic Infections and Diagnosed Patients With Covid-19 in Shanghai
N/ARecruiting
250,000 participants
Started: Mar 29, 2022 · Completed: May 31, 2032
1 condition1 sponsor1 location
NCT05247255
Quadratus Lumborum Block for Total Hip Arthroplasty
EARLY_PHASE1Recruiting
80 participants
Started: Mar 29, 2022 · Completed: Jan 31, 2027
1 condition1 sponsor1 location
NCT05505669
Circulating Biomarkers in the Development of Type 1 Diabetes
N/ARecruiting
165 participants
Started: Mar 29, 2022 · Completed: Dec 21, 2025
1 condition3 sponsors1 location
NCT05154331
Antenatal and Postnatal Care Research Collective - Household Survey (ARCH)
N/ARecruiting
7,500 participants
Started: Mar 29, 2022 · Completed: Jun 1, 2026
2 conditions3 sponsors1 location
NCT05368467
National Registry and Cohort Study of Pulmonary Vascular Disease
N/ARecruiting
1,000 participants
Started: Mar 29, 2022 · Completed: Dec 30, 2028
1 condition1 sponsor13 locations
NCT05065957
Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Tract Cancer
PHASE2/PHASE3Recruiting
180 participants
Started: Mar 29, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor5 locations
NCT05241093
A Study of HYML-122 and Cytarabine in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
PHASE2Recruiting
18 participants
Started: Mar 29, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05479669
Value of Intense Phenotyping in Heart Failure With Preserved Ejection Fraction
N/ARecruiting
200 participants
Started: Mar 29, 2022 · Completed: Jan 1, 2031
1 condition1 sponsor1 location